HIV and AIDS: Lords Committee to hear from vaccine and treatment research specialists
1 March 2011
The House of Lords Committee on HIV and AIDS in the UK will tomorrow take evidence from a range of experts in vaccine and treatment research and development.
The Committee will hear from the following witnesses:
10:15am
- Rhon Reynolds, Advocacy Specialist Europe, International AIDS Vaccine Initiative
- Dr Emmanuel Cormier PhD, Clinical Immunology Manager, International AIDS Vaccine Initiative
- Mary Kerr, Vice President and Head of ViiV Healthcare Europe, ViiV Healthcare
- Lisa Bright, General Manager UK and Ireland, Gilead Sciences
11:15am
- Professor Sir Andrew McMichael, Director, Weatherall Institute of Molecular Medicine, Oxford University
- Professor Jonathan Weber, Deputy Principal (Research), Faculty of Medicine, Imperial College London
- Dr Sheena McCormack, Clinical Epidemiologist, Medical Research Council Clinical Trials Unit
The Committee is investigating issues relating to the monitoring, testing, treatment, prevention and stigma of HIV and AIDS.
The witnesses will be asked questions in relation to: progress made towards an HIV vaccine; agenda-setting for HIV research in the UK; the major unanswered questions in understanding HIV; and the anticipated effect on HIV treatment and care from the prospect of price competition in the Health and Social Care Bill.
The Evidence session will take place from 10.15am on Tuesday 1 March in Committee Room 2 of the House of Lords.